American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 169-180 , August 2007

Testing for Chronic Kidney Disease: A Position Statement From the National Kidney Foundation

  • Joseph A. Vassalotti, MD

      Affiliations

    • National Kidney Foundation, New York, NY
    • ,
  • Lesley A. Stevens, MD, MS

      Affiliations

    • NKF Center for Guideline Development and Implementation, Tufts-New England Medical Center, Boston, MA.
    • Corresponding Author InformationAddress correspondence to Lesley A. Stevens, MD, MS, Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box #391, Boston, MA 02111.
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • NKF Center for Guideline Development and Implementation, Tufts-New England Medical Center, Boston, MA.

References 

  1. Collins AJ, Couser WG, Dirks JH, et al. World Kidney Day: An idea whose time has come. J Am Soc Nephrol. 2006;17:600–601
  2. Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. CKD: Common, harmful, and treatable—World Kidney Day 2007. Am J Kidney Dis. 2007;49:175–179
  3. Levey AS, Atkins T, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives: A Position Statement from KDIGO. Kidney Int. 2007;(in press)
  4. Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease; A public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3:A57
  5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (Kidney Disease Outcome Quality Initiative). Am J Kidney Dis. 2002;39(suppl 1):1–266
  6. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  7. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  8. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–3741
  9. Coresh J, Byrd-Holt D, Astor B, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  10. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284
  11. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14(suppl 2):S131–S138
  12. Chen J, Wildman RP, Gu D, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68:2837–2845
  13. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  14. Stevens LA, Fares G, Fleming J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005;16:2439–2448
  15. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  16. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200
  17. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495
  18. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?. Am J Kidney Disease. 1998;32:853–905
  19. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  20. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  21. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  22. Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(suppl 1):S79–S83
  23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (Kidney Disease Outcome Quality Initiative). Am J Kidney Dis. 2004;43(suppl 1):S1–S290
  24. Mann JF, Gerstein HC, Yi QL, et al. Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol. 2003;14:641–647
  25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  26. Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr)
  27. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  28. Stevens L, Coresh J, Deysher A, et al. Evaluation of the MDRD study equation in a diverse population. J Am Soc Nephrol. 2006;17:143A
  29. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
  30. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50
  31. Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W. An alternative formula to the Cockcroft-Gault and the modification of diet in renal disease formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol. 2005;16:1051–1060
  32. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16:459–466
  33. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929–937
  34. Stevens L, Manzi J, Levey A, et al. Impact of creatinine standardization on performance of GFR estimating equations. J Am Soc Nephrol. 2006;17:143A
  35. Levey AS, Stevens LA, Hostetter T. Automatic reporting of estimated glomerular filtration rate–Just what the doctor ordered. Clin Chem. 2006;52:2188–2193
  36. Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–772
  37. Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA. 2003;290:3101–3114
  38. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10:1281–1286
  39. Myers G, Miller W, Coresh J, et al. Recommendations for improving serum creatinine measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52:5–18
  40. Harwell TS, Nelson RG, Little RR, McDowall JM, Helgerson SD, Gohdes D. Testing for microalbuminuria in 2002: Barriers to implementing current guidelines. Am J Kidney Dis. 2003;42:245–248
  41. Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors–United States, 1999-2004. MMWR. 2007;56:161–165
  42. National Kidney Foundation. Kidney Early Evaluation Program 2006 Annual Data Report. Am J Kidney Dis. 2007;49(suppl 1):S1–S160

PII: S0272-6386(07)00943-2

doi: 10.1053/j.ajkd.2007.06.013

American Journal of Kidney Diseases
Volume 50, Issue 2 , Pages 169-180 , August 2007

Article Tools

* Image Usage & Resolution